The potential diagnostic value of extracellular vesicle miRNA for human non-small cell lung cancer: a systematic review and meta-analysis

References

• Kanaoka R, Iinuma H, Dejima H, et al. Usefulness of plasma exosomal MicroRNA-451a as a noninvasive biomarker for early prediction of recurrence and prognosis of non-small cell lung cancer. Oncology. 2018;94(5):311–323. Epub 2018/03/14. PubMed PMID: 29533963.
   PubMed Web of Science ®Google Scholar
• Mangal S, Gao W, Li T, et al. Pulmonary delivery of nanoparticle chemotherapy for the treatment of lung cancers: challenges and opportunities. Acta Pharmacol Sin. 2017;38(6):782–797. Epub 2017/05/16. PubMed PMID: 28504252; PubMed Central PMCID: PMCPMC5520191.
   PubMed Web of Science ®Google Scholar
• Li L, Sun Y, Feng M, et al. Clinical significance of blood-based miRNAs as biomarkers of non-small cell lung cancer. Oncol Lett. 2018;15(6):8915–8925. Epub 2018/05/29. PubMed PMID: 29805626; PubMed Central PMCID: PMCPMC5958758.
   PubMed Web of Science ®Google Scholar
• Li Y, Zhang Y, Qiu F, et al. Proteomic identification of exosomal LRG1: a potential urinary biomarker for detecting NSCLC. Electrophoresis. 2011;32(15):1976–1983. Epub 2011/05/11. PubMed PMID: 21557262.
   PubMed Web of Science ®Google Scholar
• Yang Y, Kannisto E, Yu G, et al. An immuno-biochip selectively captures tumor-derived exosomes and detects exosomal RNAs for cancer diagnosis. Int J Nanomed. 2018;10(50):43375–43386. Epub 2019/10/22. PubMed PMID: 30451486; PubMed Central PMCID: PMCPmc6790351.
   Google Scholar
• Gumireddy K, Li A, Chang DH, et al. AKAP4 is a circulating biomarker for non-small cell lung cancer. Oncotarget. 2015;6(19):17637–17647. Epub 2015/07/15. PubMed PMID: 26160834; PubMed Central PMCID: PMCPMC4627334.
   PubMed Web of Science ®Google Scholar
• Yang J, Sun G, Hu Y, et al. Extracellular vesicle lncRNA metastasis-associated lung adenocarcinoma transcript 1 released from glioma stem cells modulates the inflammatory response of microglia after lipopolysaccharide stimulation through regulating miR-129-5p/high mobility group Box-1 protein axis. Front Immunol. 2019;10:3161. Epub 2020/03/03. PubMed PMID: 32117213; PubMed Central PMCID: PMCPMC7020807.
   PubMed Web of Science ®Google Scholar
• Liu Q, Xiang Y, Yuan S, et al. Plasma exosome levels in non-small-cell lung cancer: correlation with clinicopathological features and prognostic implications. Cancer Biomarkers. 2018;22(2):267–274. Epub 2018/04/18. PubMed PMID: 29660899.
   PubMed Web of Science ®Google Scholar
• Urban SK, Sänger H, Krawczyk M, et al. Synergistic effects of extracellular vesicle phenotyping and AFP in hepatobiliary cancer differentiation. Liver Int. 2020;40(12):3103–3116. Epub 2020/07/03. PubMed PMID: 32614460.
   PubMed Web of Science ®Google Scholar
• Shan X, Zhang H, Zhang L, et al. Identification of four plasma microRNAs as potential biomarkers in the diagnosis of male lung squamous cell carcinoma patients in China. Cancer Med. 2018;7(6):2370–2381. Epub 2018/04/20. PubMed PMID: 29673101; PubMed Central PMCID: PMCPMC6010830.
   PubMed Web of Science ®Google Scholar
• Chen L, Cao P, Huang C, et al. Serum exosomal miR-7977 as a novel biomarker for lung adenocarcinoma. J Cell Biochem. 2020;121(5–6):3382–3391. Epub 2020/01/04. PubMed PMID: 31898829.
   PubMed Web of Science ®Google Scholar
• Hydbring P, De Petris L, Zhang Y, et al. Exosomal RNA-profiling of pleural effusions identifies adenocarcinoma patients through elevated miR-200 and LCN2 expression. Lung Cancer. 2018;124:45–52. Epub 2018/10/01. PubMed PMID: 30268479.
   PubMed Web of Science ®Google Scholar
• Cazzoli R, Buttitta F, Di Nicola M, et al. microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J Thorac Oncol. 2013;8(9):1156–1162. Epub 2013/08/16. PubMed PMID: 23945385; PubMed Central PMCID: PMCPMC4123222.
   PubMed Web of Science ®Google Scholar
• Han Z, Li Y, Zhang J, et al. Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage lung adenocarcinoma. Int J Med Sci. 2020;17(10):1428–1438. Epub 2020/07/07. PubMed PMID: 32624699; PubMed Central PMCID: PMCPMC7330662.
   PubMed Web of Science ®Google Scholar
• Xia Y, Wei K, Hu LQ, et al. Exosome-mediated transfer of miR-1260b promotes cell invasion through Wnt/β-catenin signaling pathway in lung adenocarcinoma. J Cell Physiol. 2020;235(10):6843–6853. Epub 2020/02/07. PubMed PMID: 32026462.
   Web of Science ®Google Scholar
• Zhou X, Wen W, Shan X, et al. A six-microRNA panel in plasma was identified as a potential biomarker for lung adenocarcinoma diagnosis. J Diabetes Res. 2017;8(4):6513–6525. Epub 2017/03/02. PubMed PMID: 28036284; PubMed Central PMCID: PMCPmc5299189Pmc5351649.
   Google Scholar
• Jin X, Chen Y, Chen H, et al. Evaluation of tumor-derived exosomal miRNA as potential diagnostic biomarkers for early-stage non-small cell lung cancer using next-generation sequencing. Clin Cancer Res off J Am Assoc Cancer Res. 2017;23(17):5311–5319. Epub 2017/06/18. PubMed PMID: 28606918.
   PubMed Web of Science ®Google Scholar
• Czarnecka KH, Szmyd B, Barańska M, et al. A strong decrease in TIMP3 expression mediated by the presence of miR-17 and 20a enables extracellular matrix remodeling in the NSCLC lesion surroundings. Front Oncol. 2019;9:1372. Epub 2020/01/11. PubMed PMID: 31921636; PubMed Central PMCID: PMCPMC6923190.
   PubMed Web of Science ®Google Scholar
• Liu C, Kannisto E, Yu G, et al. Non-invasive detection of exosomal MicroRNAs via tethered cationic lipoplex nanoparticles (tCLN) biochip for lung cancer early detection. Front Genet. 2020;11:258. Epub 2020/04/09. PubMed PMID: 32265989; PubMed Central PMCID: PMCPMC7100709.
   PubMed Web of Science ®Google Scholar
• Wu Q, Yu L, Lin X, et al. Combination of serum miRNAs with serum exosomal miRNAs in early diagnosis for non-small-cell lung cancer. Cancer Manag Res. 2020;12:485–495. Epub 2020/02/06. PubMed PMID: 32021461; PubMed Central PMCID: PMCPMC6982436.
   PubMed Web of Science ®Google Scholar
• Tamiya H, Mitani A, Saito A, et al. Exosomal MicroRNA expression profiling in patients with lung adenocarcinoma-associated malignant pleural effusion. Anticancer Res. 2018;38(12):6707–6714. Epub 2018/12/07. PubMed PMID: 30504380.
   PubMed Web of Science ®Google Scholar
• Wang N, Guo W, Song X, et al. Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer. Clin Chem Lab Med. 2020;58(9):1535–1545. Epub 2020/04/10. PubMed PMID: 32271158.
   Web of Science ®Google Scholar
• Zhang Y, Zhang Y, Yin Y, et al. Detection of circulating exosomal miR-17-5p serves as a novel non-invasive diagnostic marker for non-small cell lung cancer patients. Pathol Res Pract. 2019;215(8):152466. Epub 2019/05/31. PubMed PMID: 31146974.
   PubMed Web of Science ®Google Scholar
• Liu W, Liu J, Zhang Q, et al. Downregulation of serum exosomal miR-216b predicts unfavorable prognosis in patients with non-small cell lung cancer. Cancer Biomarkers. 2020;27(1):113–120. Epub 2019/11/28. PubMed PMID: 31771047.
   PubMed Web of Science ®Google Scholar
• Yao B, Qu S, Hu R, et al. A panel of miRNAs derived from plasma extracellular vesicles as novel diagnostic biomarkers of lung adenocarcinoma. FEBS Open Bio. 2019;9(12):2149–2158. Epub 2019/11/05. PubMed PMID: 31677346; PubMed Central PMCID: PMCPMC6886307.
   PubMed Web of Science ®Google Scholar
• Fang H, Liu Y, He Y, et al. Extracellular vesicle‑delivered miR‑505‑5p, as a diagnostic biomarker of early lung adenocarcinoma, inhibits cell apoptosis by targeting TP53AIP1. Int J Oncol. 2019;54(5):1821–1832. Epub 2019/03/14. PubMed PMID: 30864684.
   PubMed Web of Science ®Google Scholar
• Yang G, Wang T, Qu X, et al. Exosomal miR-21/let-7a ratio distinguishes non-small cell lung cancer from benign pulmonary diseases. Asia Pac J Clin Oncol. 2020;16(4):280–286. Epub 2020/06/12. PubMed PMID: 32525285.
   PubMed Web of Science ®Google Scholar
• Lee LJ, Yang Z, Rahman M, et al. Extracellular mRNA detected by tethered lipoplex nanoparticle biochip for lung adenocarcinoma detection. Am J Respir Crit Care Med. 2016;193(12):1431–1433. Epub 2016/06/16. PubMed PMID: 27304243; PubMed Central PMCID: PMCPMC4910892.
   PubMed Web of Science ®Google Scholar
• Jin JJ, Liu YH, Si JM, et al. Overexpression of miR-1290 contributes to cell proliferation and invasion of non small cell lung cancer by targeting interferon regulatory factor 2. Int J Biochem Cell Biol. 2018;95:113–120. Epub 2017/12/25. PubMed PMID: 29275213.
   PubMed Web of Science ®Google Scholar
• Yu JJ, Pi WS, Cao Y, et al. let-7a inhibits osteosarcoma cell growth and lung metastasis by targeting Aurora-B. Cancer Manag Res. 2018;10:6305–6315. Epub 2018/12/21. PubMed PMID: 30568492; PubMed Central PMCID: PMCPMC6267740.
   PubMed Web of Science ®Google Scholar
• Wang YY, Ren T, Cai YY, et al. MicroRNA let-7a inhibits the proliferation and invasion of nonsmall cell lung cancer cell line 95D by regulating K-Ras and HMGA2 gene expression. Cancer Biother Radiopharm. 2013;28(2):131–137. Epub 2012/11/09. PubMed PMID: 23134218.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang Y, Du X, et al. MiR-216b suppresses cell proliferation, migration, invasion, and epithelial-mesenchymal transition by regulating FOXM1 expression in human non-small cell lung cancer. Onco Targets Ther. 2019;12:2999–3009. Epub 2019/05/23. PubMed PMID: 31114243; PubMed Central PMCID: PMCPMC6489682.
   PubMed Web of Science ®Google Scholar
• Liu S, Dong H, Dai H, et al. MicroRNA-216b regulated proliferation and invasion of non-small cell lung cancer by targeting SOX9. Oncol Lett. 2018;15(6):10077–10083. Epub 2018/06/22. PubMed PMID: 29928377; PubMed Central PMCID: PMCPMC6004665.
   PubMed Web of Science ®Google Scholar
• Li Q, Li X, Guo Z, et al. MicroRNA-574-5p was pivotal for TLR9 signaling enhanced tumor progression via down-regulating checkpoint suppressor 1 in human lung cancer. PloS One. 2012;7(11):e48278. Epub 2012/11/08. PubMed PMID: 23133627; PubMed Central PMCID: PMCPMC3487732.
   PubMed Web of Science ®Google Scholar
• Sarver AL, Li L, Subramanian S. MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. Cancer Res. 2010;70(23):9570–9580. Epub 2010/12/02. PubMed PMID: 21118966.
   PubMed Web of Science ®Google Scholar
• Yang F, Yan Y, Yang Y, et al. MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN/PI3K/AKT pathway. Cell Signal. 2020;73:109675. Epub 2020/05/25. PubMed PMID: 32446904.
   PubMed Web of Science ®Google Scholar
• Meng W, Ye Z, Cui R, et al. MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. Clin Cancer Res off J Am Assoc Cancer Res. 2013;19(19):5423–5433. Epub 2013/08/16. PubMed PMID: 23946296; PubMed Central PMCID: PMCPMC3823052.
   PubMed Web of Science ®Google Scholar
• Huang X. Cotton dust exposure and risk of lung cancer: a meta-analysis of observational studies. Medicine (Baltimore). 2020;99(14):e19565. Epub 2020/04/04. PubMed PMID: 32243374.
   PubMed Web of Science ®Google Scholar
• Yuwen DL, Sheng BB, Liu J, et al. MiR-146a-5p level in serum exosomes predicts therapeutic effect of cisplatin in non-small cell lung cancer. Eur Rev Med Pharmacol Sci. 2017;21(11):2650–2658. Epub 2017/07/06. PubMed PMID: 28678319.
   PubMed Web of Science ®Google Scholar
• Sun HJ, Zhu XX, Cai WW, et al. Functional roles of exosomes in cardiovascular disorders: a systematic review. Eur Rev Med Pharmacol Sci. 2017;21(22):5197–5206. Epub 2017/12/12. PubMed PMID: 29228434.
   PubMed Web of Science ®Google Scholar
• Zhang L, Hao C, Zhai R, et al. Downregulation of exosomal let-7a-5p in dust exposed- workers contributes to lung cancer development. Respir Res. 2018;19(1):235. Epub 2018/12/01. PubMed PMID: 30497474; PubMed Central PMCID: PMCPMC6267915.
   PubMedGoogle Scholar
• Wen W, Liu P, Xu H, et al. Serum exosomal long noncoding RNAs ENSG00000258332.1 and LINC00635 for the diagnosis and prognosis of hepatocellular carcinoma. Cancer Med. 2018;27(6):710–716. Epub 2018/04/20. PubMed PMID: 29650788; PubMed Central PMCID: PMCPmc6010830.
   Google Scholar
• Zheng M, Hou L, Ma Y, et al. Exosomal let-7d-3p and miR-30d-5p as diagnostic biomarkers for non-invasive screening of cervical cancer and its precursors. Mol Cancer. 2019;18(1):76. Epub 2019/04/04. PubMed PMID: 30940131; PubMed Central PMCID: PMCPmc6446401.
   PubMedGoogle Scholar
• Lux A, Kahlert C, Grutzmann R, et al. c-Met and PD-L1 on circulating exosomes as diagnostic and prognostic markers for pancreatic cancer. Int J Mol Sci. 2019;20(13). DOI:10.3390/ijms20133305. PubMed PMID: 31284422.
   PubMed Web of Science ®Google Scholar
• Samsonov R, Burdakov V, Shtam T, et al. Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer. Tumour Biol. 2016;37(9):12011–12021. Epub 2016/10/27. PubMed PMID: 27164936.
   PubMedGoogle Scholar
• Sun B, Li Y, Zhou Y, et al. Circulating exosomal CPNE3 as a diagnostic and prognostic biomarker for colorectal cancer. J Cell Physiol. 2019;234(2):1416–1425. Epub 2018/08/06. PubMed PMID: 30078189.
   PubMed Web of Science ®Google Scholar
• Bersani F, Morena D, Picca F, et al. Future perspectives from lung cancer pre-clinical models: new treatments are coming? Transl Lung Cancer Res. 2020;9(6):2629–2644. Epub 2021/01/26. PubMed PMID: 33489823; PubMed Central PMCID: PMCPMC7815341.
   PubMed Web of Science ®Google Scholar
• Wu Y, Wei J, Zhang W, et al. Serum exosomal miR-1290 is a potential biomarker for lung adenocarcinoma. Onco Targets Ther. 2020;13:7809–7818. Epub 2020/08/18. PubMed PMID: 32801784; PubMed Central PMCID: PMCPMC7415459.
   PubMed Web of Science ®Google Scholar
• Zhong S, Golpon H, Zardo P, et al. miRNAs in lung cancer. A systematic review identifies predictive and prognostic miRNA candidates for precision medicine in lung cancer. Transl Res J Lab Clin Med. 2021;230:164–196. Epub 2020/12/01. PubMed PMID: 33253979.
   Google Scholar